Autologous cell therapy for HIV: Stem cells, ribozymes and HIV

Gene Therapy

Volumn 16, Issue 10, 2009, Pages 1178-1179

  Burnett, J C ^a   Rossi, J J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMARETROVIRUS VECTOR; GENE PRODUCT; LENTIVIRUS VECTOR; PROTEIN OZ1; RETROVIRUS VECTOR; RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; RIBOZYME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD34 SELECTION; CD4+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; NOTE; OPEN READING FRAME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; T CELL LEUKEMIA; VIRAL GENE DELIVERY SYSTEM; VIRUS LOAD; VIRUS REPLICATION; GENE THERAPY; GENE TRANSFER; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; RNA, CATALYTIC;

EID: 70350203995     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.86     Document Type: Note

References (10)

1. Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, Workman C et al. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med 2009; 15: 285-292.
2. Rossi JJ, June CH, Kohn DB. Genetic therapies against HIV. Nat Biotechnol 2007; 25: 1444-1454.
3. Baltimore D. Gene therapy. Intracellular immunization. Nature 1988; 335: 395-396.
4. Amado RG, Mitsuyasu RT, Rosenblatt JD, Ngok FK, Bakker A, Cole S et al. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther 2004; 15: 251-262.
5. Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, Cohen EA. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 2007; 3: E85.
6. Canny MD, Jucker FM, Kellogg E, Khvorova A, Jayasena SD, Pardi A. Fast cleavage kinetics of a natural hammerhead ribozyme. J Am Chem Soc 2004; 126: 10848-10849.
7. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008; 118: 3132-3142.
8. Li MJ, Kim J, Li S, Zaia J, Yee JK, Anderson J et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther 2005; 12: 900-909.
9. An DS, Donahue RE, Kamata M, Poon B, Metzger M, Mao SH et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in nonhuman primates. Proc Natl Acad Sci USA 2007; 104: 13110-13115.
10. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26: 808-816.